References
- Hulka BS, Kaufman DG, Fowler WC, Grimson RC, Greenberg BG. Predominance of early endometrial cancers after long-term estrogen use. J Am Med Assoc 1980;244:2419–21
- Voigt LF, Weiss NS, Chu J, Dating JR, McKnight B, van Belle G. Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991;338:274–7
- Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17B-estradiol: comparison with conventional oral estrogens used for hormone replacement therapy. Am J Obstet Gynecol 1985;152: 1099–106
- Lauritzen C. Percutaneous estrogen therapy: a modern option in the treatment of climacteric syndrome. In Birkhäuser MH, Rozenbaum H, eds. European Congress on Menopause, Vienna, Austria: Editions ESKA, 1998:155–7
- King RJ, Whitehead MI. Assessment of the potency of orally administered progestins in women. Fertil Steril 1986;46:1062–6
- Ryder TA, Mobberley MA, Whitehead MI. The endometrial nucleolar channel test as an indica-tor of progestin potency in HRT. Maturitas 1995; 22:31–6
- Whitehead MI, Townsend PT, Pryse-Davies J, et al. Effects of various types and dosages of progestogens on the postmenopausal endo-metrium. J Reprod Med 1982;27:39–48
- Friend DR, Catz P, Phillips S. Transdermal delivery of levonorgestrel: VII. In vivo studies. Contraception 1989;40:73–80
- Friend DR. Transdermal delivery of levonor-gestrel. Med Res Rev 1991;11:49–80
- van de Weijer PHM, Mol M, Biesheuvel E. Vaginal bleeding patterns in sequential regimens of estradiol with dydrogesterone. Eur Meno-pause J 1995;2:9–15
- Betsey EM, Farley TM. The analysis of menstrual bleeding patterns: a review. Contraception 1988; 38:129–56
- Betsey EM, Machin D, d'Aracangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 1986;34:253–60
- Kupperman HS, Blatt HGM, Wiesbader H. Com-parative clinical evaluation of estrogen prepara-tions by menopausal and amenorrheal indices. J Clin Endocrinol 1953;13:688–703
- van de Weijer PHM, Barentsen R, de Vries M, Kenemans P. Relationship of estradiol levels to breakthrough bleeding during continuous com-bined hormone replacement therapy. Obstet Gynecol 1999;93:551–7
- Dören M, Schneider HPG. Long-term compli-ance of continuous combined estrogen and progestogen replacement in postmenopausal women. Maturitas 1996;25:99–105
- Magos AL, Brincat M, Studd JWW, Wardle P, Schlesinger P, O'Dowd 0. Amenorrhoea and endometrial atrophy with continuous oral estro-gens and progestogen therapy in postmenopausal women. Obstet Gynecol 1985;65:496–9
- van de Weijer PHM, Barentsen R, Kenemans P. Women's expectations and acceptance of cyclic induced HRT bleeds. Maturitas 1998;30:257–63